Pharmaceuticals Are Heavily Outsourced. Can the U.S. Make More of it Here?
The U.S. is increasingly dependent on imports for drugs. One reason: a tax avoidance scheme that pits U.S. manufacturing up against Europe. What can be done about this problem?
CPA Applauds Bipartisan Legislation to Repeal Biden Solar Emergency Declaration that Allows Tariff Free Importation of Subsidized Chinese Solar to Continue Illegal Trade Activity
WASHINGTON — The Coalition for a Prosperous America (CPA) today applauded bipartisan legislation introduced by U.S. Representatives Bill Posey (R-FL) and Dan Kildee (D-MI) that
Americas Act Addresses Key Failure of Past Trade Deals
U.S. Senator Bill Cassidy (R-LA) has released a discussion draft of a sweeping, ambitious bill titled the “Americas Act”. The bill states its aim to
U.S. Domestic Market Share Index Increases Slightly
WASHINGTON — The Coalition for a Prosperous America (CPA) today released an update to the Domestic Market Share Index (DMSI), a new indicator that measures
European Pharma Considers Reshoring from India, China. Where’s the US?
The Covid-19 pandemic gave big pharma big payday. But it also caused the industry to rethink a globalized supply chain centered on Asia. What will it take to reshore at least some generic drugs to the U.S.
CPA Submits Comments to USTR in Support of Section 301 China Tariffs
WASHINGTON — The Coalition for a Prosperous America (CPA) submitted comments to Ambassador Katherine Tai in support of continuing the Section 301 China Tariffs. The
Duty-Free Steel Imports from Mexico Surge Beyond Agreed Upon Levels
U.S. steel imports from Mexico have surged despite a 2019 U.S.-Mexico agreement to maintain steel imports at past levels.